![Frontiers | Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies | Immunology Frontiers | Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies | Immunology](https://www.frontiersin.org/files/Articles/559710/fimmu-11-02054-HTML-r1/image_m/fimmu-11-02054-g001.jpg)
Frontiers | Mucins in Intestinal Mucosal Defense and Inflammation: Learning From Clinical and Experimental Studies | Immunology
![Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease - Journal of Hepatology Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease - Journal of Hepatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3975e299-51ba-482a-88eb-2c15b4ab7a01/fx1_lrg.jpg)
Pan-PPAR agonist lanifibranor improves portal hypertension and hepatic fibrosis in experimental advanced chronic liver disease - Journal of Hepatology
![Gastrointestinal cancer organoids—applications in basic and translational cancer research | Experimental & Molecular Medicine Gastrointestinal cancer organoids—applications in basic and translational cancer research | Experimental & Molecular Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs12276-021-00654-3/MediaObjects/12276_2021_654_Fig1_HTML.png)